Log in to save to my catalogue

Evaluation of the Safety and Tolerability of Plecanatide in CIC and IBS-C Patients Aged 65 and Older...

Evaluation of the Safety and Tolerability of Plecanatide in CIC and IBS-C Patients Aged 65 and Older...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2580881423

Evaluation of the Safety and Tolerability of Plecanatide in CIC and IBS-C Patients Aged 65 and Older: 427

About this item

Full title

Evaluation of the Safety and Tolerability of Plecanatide in CIC and IBS-C Patients Aged 65 and Older: 427

Publisher

New York: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

Journal title

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S251-S251

Language

English

Formats

Publication information

Publisher

New York: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

More information

Scope and Contents

Contents

Introduction: Constipation, including Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C), is prevalent in patients aged 65 and older. Currently, there is limited clinical trial safety/tolerability data in older adults. Recently, two CIC and two IBS-C trials with plecanatide were completed which represent th...

Alternative Titles

Full title

Evaluation of the Safety and Tolerability of Plecanatide in CIC and IBS-C Patients Aged 65 and Older: 427

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2580881423

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2580881423

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.14309/00000434-201810001-00427

How to access this item